NEW YORK, May 26, 2011 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), the financial information and technology services company that provides the world's largest electronic marketplace for broker-dealers to trade unlisted stocks, today announced that Verisante Technology Inc. (TSX.V: VRS; OTCQX: VRSEF), a medical device company committed to commercializing innovative systems for the early detection of cancer, is now trading on the OTC market's highest tier, OTCQX®.
Verisante began trading today on the OTC market's prestigious tier, OTCQX International. Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcqx.com and www.otcmarkets.com.
"The superior information and visibility of the OTCQX marketplace allows companies to efficiently build investor confidence and expand their shareholder base," said R. Cromwell Coulson, President and Chief Executive Officer of OTC Markets Group. "We are pleased to welcome Verisante Technology to OTCQX."
Hodgson Russ LLP will serve as Verisante's Principal American Liaison ("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements.
About Verisante Technology Inc.
Verisante Technology Inc. (TSX.V: VRS; OTCQX: VRSEF) trades in the United States on OTCQX under the symbol "VRSEF". Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. Our exclusive platform technology allows us to develop and offer a range of compact, non-invasive cancer detection devices that offe